$690 Million is the total value of Hillhouse Capital Management's 18 reported holdings in Q1 2013. The portfolio turnover from Q4 2012 to Q1 2013 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q1 2013 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MONDELEZ INTL INC | 22 | Q3 2018 | 44.4% |
JD COM INC | 19 | Q2 2019 | 80.2% |
SOHU COM INC | 19 | Q1 2018 | 13.4% |
58 COM INC | 18 | Q3 2018 | 7.8% |
TAL EDUCATION GROUP | 18 | Q2 2019 | 4.4% |
CTRIP COM INTL LTD | 17 | Q2 2017 | 28.4% |
BEIGENE LTD | 14 | Q2 2019 | 25.2% |
MELCO RESORT ENTERTAINMENT L | 14 | Q3 2018 | 6.4% |
CAMECO CORP | 14 | Q4 2017 | 2.2% |
ENSTAR GROUP LIMITED | 12 | Q2 2019 | 21.9% |
View Hillhouse Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Hesai Group | March 05, 2024 | 4,739,545 | 5.0% |
Gossamer Bio, Inc. | February 14, 2024 | 4,974,041 | 2.2% |
Legend Biotech Corp | February 14, 2024 | 13,052,732 | 3.6% |
Sagimet Biosciences Inc. | February 14, 2024 | 1,449,543 | 6.8% |
China Jo-Jo Drugstores Holdings, Inc. | February 14, 2023 | 403,334 | 4.7% |
TScan Therapeutics, Inc. | February 14, 2023 | ? | ? |
Enfusion, Inc. | February 14, 2022 | 4,975,183 | 7.6% |
Enstar Group LTD | July 19, 2021 | ? | ? |
Zoom Video Communications, Inc. | February 16, 2021 | 2,981,265 | 1.5% |
NIO Inc. | February 14, 2020 | ? | ? |
View Hillhouse Capital Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-30 |
13F-NT | 2024-08-14 |
13F-NT | 2024-05-14 |
SC 13G/A | 2024-03-05 |
13F-NT | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
4 | 2024-02-01 |
View Hillhouse Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.